iSpecimen Inc. (Nasdaq: ISPC), an online marketplace connecting medical researchers with human biospecimens, has closed its previously announced underwritten public offering, raising gross proceeds of approximately $4 million through the sale of 5,714,283 shares of common stock (or pre-funded warrants in lieu thereof), at a public offering price of $0.70 per share.
Lucosky Brookman LLP served as legal counsel to WestPark Capital, Inc., which acted as the sole book-running manager for the offering.
